Yield10 Bioscience, Inc. (YTEN)
OTCMKTS: YTEN · Delayed Price · USD
1.700
+0.090 (5.59%)
Jul 22, 2024, 10:10 AM EDT - Market open
Yield10 Bioscience Employees
Yield10 Bioscience had 29 employees as of December 31, 2023. The number of employees decreased by 1 or -3.33% compared to the previous year.
Employees
29
Change (1Y)
-1
Growth (1Y)
-3.33%
Revenue / Employee
$12,414
Profits / Employee
-$453,276
Market Cap
1.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CRH plc | 78,500 |
Vale S.A. | 66,807 |
Linde | 66,323 |
The Sherwin-Williams Company | 64,088 |
Rio Tinto Group | 53,771 |
Ecolab | 48,000 |
BHP Group | 42,319 |
Freeport-McMoRan | 27,200 |
YTEN News
- 4 days ago - Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets - GlobeNewsWire
- 5 weeks ago - Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Announces Delisting from Nasdaq - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Announces 1-for-24 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 - GlobeNewsWire